...

Merus N.V.

Visit website

About the employer

Merus is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics®. Biclonics®, which are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical studies to have similar features as conventional monoclonal antibodies, such as long half-life and low immunogenicity.

Employer location

Discover similar employers

...
University of Luxembourg Luxembourg 102 open positions
...
KU Leuven Leuven, Belgium 101 open positions
...
Eindhoven University of Technology Netherlands 86 open positions
...
Ghent University Ghent, Belgium 70 open positions
...
University of Twente Enschede, Netherlands 62 open positions
More employers

This might interest you

...
5 Reasons to Pursue Your PhD at EMBL European Molecular Biology Laboratory (EMBL) 4 min read
...
Deciphering the Gut’s Clues to Our Health University of Turku 5 min read
...
Understanding Users to Optimise 3D Experiences Centrum Wiskunde & Informatica (CWI) 5 min read
...
Harnessing the Rhizosphere to Protect Our Soil Free University of Bozen - Bolzano 5 min read
More stories